Preview

Ural Medical Journal

Advanced search

Creutzfeldt-Jakob disease. Case from clinical practice

https://doi.org/10.25694/URMJ.2018.11.11

Abstract

Creutzfeldt-Jakob disease is a rare degenerative, prion disease of the brain. The causative agent of prion diseases is an infectious prion protein Prion Protein-scarpie (PrPSc), formed as a result of changes in the normal (non - infectious) cell protein Prion Protein-cellular (Rgrs). Accumulation of the pathological form of PrPSc leads to mass death of nerve cells. The main clinical manifestations of the disease include rapidly progressive cognitive impairment, myoclonus, dystonia, kinetically syndrome, spasticity, hyperreflexia, ataxia, visual disturbances, in the later stages of the disease akinetic mutism. About a third of the cases are epileptic seizures. The average life expectancy is about 5 months. More than 90% of patients die within 1 year due to aspiration pneumonia in the state of akinetic mutism. The complexity of diagnosis of CDR is associated with the rarity of the disease, clinical polymorphism and lack of awareness of doctors.

About the Authors

Yu. S. Bagaeva
ООО МО «Новая больница»
Russian Federation


M. G. Toporkova
ООО МО «Новая больница»
Russian Federation


L. I. Volkova
ФГБОУ ВО «Уральский государственный медицинский университет» Минздрава России
Russian Federation


References

1. Переседова А.В., Завалишин И.А. Болезнь Крейтцфельдта-Якоба: современные аспекты проблемы (обзор литературы). Анналы клинической и экспериментальной неврологии. 2012; 1: 57-63.

2. Ludewigs H., Zuber C., Vana K. Therapeutic approaches for prion disorders. Expert Rev. Anti. Infect. Ther 2007; 5: 613-30.

3. Зуев В.А., Завалишин И.А., Ройхель В.М. Прионные болезни человека и животных. Руководство для врачей. М.: Медицина, 1999; 192.

4. Kovacs G.G., Budka H. Molecular pathology of human prion diseases. Int. J. Mol. Sci. 2009; 10: 976-99.

5. Zerr I., Pocchiari M., Collins S. et al. Analysis of EEG and CSF 143-3 proteins as aids to the diagnosis of Creutzfeldt-Jakob disease. Neurology 2000; 55: 811-5.

6. Zerr I., Kallenberg K., Summers D.M. et al. Updated clinical diagnostic criteria for sporadic CreutzfeldtJakob disease. Brain 2009; 132: 2659-68.

7. Hsich G., Kenney K., Gibbs C.J. et al. The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. N. Engl. J. Med. 1996; 335: 924-30.

8. Cuadrado-Corrales N., Jimenez-Huete A., Albo C. et al. Impact of the clinical context on the 14-3-3 test for the diagnosis of sporadic CJD. BMC Neurol. 2006; 6: 25.

9. Chohan G., Pennington C., Mackenzie J.M. et al. The role of cerebrospinal fluid 14-3-3 and other proteins in the diagnosis of sporadic Creutzfeldt-Jakob disease in the UK: a 10-year review.J. Neurol. Neurosurg. Psychiatry 2010; 81: 1243-1248.


Review

For citations:


Bagaeva YS, Toporkova MG, Volkova LI. Creutzfeldt-Jakob disease. Case from clinical practice. Ural Medical Journal. 2018;(11):5-9. (In Russ.) https://doi.org/10.25694/URMJ.2018.11.11

Views: 270


ISSN 2071-5943 (Print)
ISSN 2949-4389 (Online)